Does anyone have any idea why RGS is insisting so much on Universal Cells and Viralytics respective takeovers by Astellas and Merck? Are they planning to be the next one?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025